Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 8 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Rhythm Pharmaceuticals Inc have a median target of 69.00, with a high estimate of 84.00 and a low estimate of 58.00. The median estimate represents a 15.15% increase from the last price of 59.92.
High | 40.2% | 84.00 |
Med | 15.2% | 69.00 |
Low | -3.2% | 58.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | -45.99% |
Average growth rate | -16.22% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.29% |
Average growth rate | +292.34% |
More ▼